Campbell & CO Investment Adviser LLC

Position in RPRX — Royalty Pharma plc

CIK 1353570 BALTIMORE, MD

Position in RPRX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,496,759

-$1,586,210 QoQ

Shares Held

31,202

-60.9% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

9 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Campbell & CO Investment Adviser LLC holds $45,287,811 across 43 Biotechnology names. RPRX ranks #7 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	9,034	$6,597,078
2	KRYS	Krystal Biotech, Inc.	17,795	$4,596,804
3	CRNX	Crinetics Pharmaceuticals, Inc.	83,617	$3,036,969
4	RVMD	Revolution Medicines, Inc.	29,130	$2,832,892
5	VRTX	Vertex Pharmaceuticals Inc / Ma	5,580	$2,491,693
6	TECH	BIO-TECHNE Corp	41,339	$2,160,376
7	RPRX	Royalty Pharma plc This page	31,202	$1,496,759
8	PRTA	Prothena Corp Public Ltd Co	142,587	$1,385,945

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,496,759	31,202	-60.9%	Shares	Sole	2026-05-15
2025-12-31	$3,082,969	79,787	+56.8%	Shares	Sole	2026-02-12
2025-03-31	$1,584,517	50,900	-46.5%	Shares	Sole	2025-05-14
2024-12-31	$2,429,062	95,220	+23.3%	Shares	Sole	2025-02-10
2024-09-30	$2,184,384	77,214	+25.8%	Shares	Sole	2024-11-12
2024-06-30	$1,619,065	61,398	+149.7%	Shares	Sole	2024-08-13
2024-03-31	$746,828	24,591	+91.1%	Shares	Sole	2024-05-10
2023-12-31	$361,377	12,865	+29.0%	Shares	Sole	2024-02-13
2023-06-30	$306,477	9,970	—	Shares	Sole	2023-08-11
No filing history on record for this holder in this stock.